Showing 1 - 10 of 429
protection. We use new survey data from India, the results of interviews with industry, government and multinational institutions …
Persistent link: https://www.econbiz.de/10013222046
This paper examines the role of regulation and competition in generic markets. Generics offer large potential savings to payers and consumers of pharmaceuticals. Whether the potential savings are realized depends on the extent of generic entry and uptake and the level of generic prices. In the...
Persistent link: https://www.econbiz.de/10013122264
Research on the effects of patent protection on innovation and technology transfer in the cross-country pharmaceutical industry adds to our understanding of the underlying forces driving a country's innovation level. Qian (2007) constructs a comprehensive database useful for evaluating the...
Persistent link: https://www.econbiz.de/10013069398
A patent only protects an innovator from others producing the same product, but it does not protect him from others producing better products under new patents. Therefore, one may divide up the source of competition facing an innovator into within-patent competition, which results from...
Persistent link: https://www.econbiz.de/10013225118
We examine the relationship between patent protection for pharmaceuticals and investment in development of new drugs. Patent protection has increased around the world as a consequence of the TRIPS Agreement, which specifies minimum levels of intellectual property protection for members of the...
Persistent link: https://www.econbiz.de/10013324637
pharmaceutical trade data from 1996 to 2005, we examine the role of China and India as suppliers of medicines to other middle- and … medicines from high- income countries. We find that imports of antibiotics and unspecified medicaments from India and China … significantly depress the average price of these commodities imported from high-income trading partners, suggesting that India and …
Persistent link: https://www.econbiz.de/10013067622
tuberculosis drug samples that claim to be made in India and were sold in Africa, India, and five mid-income non-African countries … in India or non-African countries. Since this finding is robust for manufacturer-drug fixed effects, one likely …
Persistent link: https://www.econbiz.de/10013312516
This paper explores the characteristics of 238 patents on 94 "inventions" contributed by major multinational innovators to the "Eco-Patent Commons", which provides royalty-free access to third parties to patented climate change related innovations. By comparing the pledged patents to other...
Persistent link: https://www.econbiz.de/10013114981
We study how the market for innovation affects enforcement of patent rights. Conventional wisdom associates the gains from trade with comparative advantage in manufacturing or marketing. We show that these gains imply that patent transactions should increase litigation risk. We identify a new...
Persistent link: https://www.econbiz.de/10013120992
Can patent protection and product market competition complement each other in enhancing incentives to innovate? In this paper, we address this question by investigating how innovation responses to a substantial policy initiative increasing product market competition interact with the strength of...
Persistent link: https://www.econbiz.de/10013064451